Electronic Monitoring of Compliance to Lipid‐Lowering Therapy in Clinical Practice
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Nonadherence to treatment is a common problem in the clinical management of hypercholesterolemic patients. This study was carried out with the aim of monitoring the daily compliance to a 6‐month course of lipid‐lowering therapy, using a microelectronic device, the Medication Event Monitoring System (MEMS™), versus pill count. Forty men with primary hypercholesterolemia were prescribed fluvastatin 1 × 40 mg daily, provided in a MEMS™ package to record the date and time of each opening of the pillbox. Thirty‐nine of 40 patients (98%) completed the study. Total cholesterol and LDL cholesterol levels decreased significantly (18% and 25%, p < 0.001) during the 6‐month therapy period. A high mean rate of compliance was achieved by MEMS™ using the following three indexes—compliance to total prescribed dose (88.8% ± 13.5%), compliance to prescribed days (82.4% ± 19.5%), and compliance to prescribed time of day (81.86% ± 19.5%)—and by pill count (93.4% ± 9.5%). In addition, the MEMS™ provided some patterns of nonadherence to medication, undetectable by pill count alone, such as a drug holiday in 38% of cases, a drug omission for more than 7 consecutive days in 9% of cases, and, conversely, use of more than the one prescribed daily dose in 47% of cases. A significant correlation between the rate of compliance and the decrease in LDL cholesterol was observed only when the compliance was assessed by MEMS™. The results indicate that MEMS™ is a useful tool for monitoring compliance in clinical practice and may possibly increase adherence to long‐term lipid‐lowering therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Cited by
Long-term persistence in use of statin therapy in elderly patients
Benner, J. S. (2002) · JAMA · doi:10.1001/jama.288.4.455 · Cited by 1,232
Dosing Frequency and Medication Adherence in Chronic Disease
Coleman, C. I., Limone, B., Sobieraj, D. M., Lee, S., Roberts, M. S., Kaur, R., & Alam, T. (2012) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2012.18.7.527 · Cited by 432
Medication Adherence and Persistence as the Cornerstone of Effective Antihypertensive Therapy
BURNIER, M. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.04.006 · Cited by 358
Self-citationInterventions to improve adherence to lipid-lowering medication
van Driel, M. L., Morledge, M. D., Ulep, R., Shaffer, J. P., Davies, P., & Deichmann, R. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004371.pub4 · Cited by 333
van den Bemt, B. J., Zwikker, H. E., & van den Ende, C. H. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.23 · Cited by 320
Metadata
- Authors
- Schwed, A., Fallab, C., Burnier, M., Waeber, B., Kappenberger, L., Burnand, B., & Darioli, R.
- Venue
- The Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1999-04
- Volume
- 39
- Issue
- 4
- Pages
- 402-409
- ISSN
- 0021-9754 (ISSN-L)
- 0091-2700
- 1552-4604
- OpenAlex
- W2019707681
- Cited by
- 79
- References
- 2
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Electronic Monitoring of Compliance to Lipid‐Lowering Therapy in Clinical Practice. https://app.cochat.ai/papers/10.1177/00912709922007976
- The paper
- Schwed, A., Fallab, C., Burnier, M., Waeber, B., Kappenberger, L., Burnand, B., & Darioli, R. (1999). Electronic Monitoring of Compliance to Lipid‐Lowering Therapy in Clinical Practice. The Journal of Clinical Pharmacology. https://doi.org/10.1177/00912709922007976
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.